Bevatas 400mg Injection: Effective Medication for Professional Results

Bevatas 400mg Injection

Uses:

• Glioblastoma multiforme (brain cancer);
• Persistent, recurrent, or metastatic breast cancer;
• Metastatic cervical cancer;
• Advanced kidney cancer;
• Metastatic colorectal cancer;
• Advanced non-small-cell lung cancer;
• Liver cancer — hepatocellular carcinoma;
• Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer.

Therapeutic effects: Bevatas 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It binds to the protein called vascular endothelial growth factor A (VEGF-A), interrupting its interaction with receptors and inhibiting the formation of blood vessels that supply oxygen and nutrients to the tumor. This slows down the rate of progression of cancer.

Administration:

• Administered intravenously as an infusion;
• The infusion should be given immediately after the dilution;
• The amount of drug is measured based on the patient’s body weight, height, and age.

Safety advice:

• Pregnancy: inform your physician before starting treatment if you are pregnant or planning for pregnancy;
• Breastfeeding: avoid breastfeeding for at least 6 months after treatment;
• Lungs: inform your doctor if you have any lung conditions;
• Liver: inform your physician before starting treatment if you have liver diseases;
• Alcohol: consult your doctor to know if it is safe to consume alcohol while on treatment;
• Driving: avoid driving or using machinery while on treatment.

Side effects:

• Serious: headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing following surgery, protein in urine, severe infections, blood clots in arteries and blood vessels of lungs, gut perforation, nosebleeds and bleeding risk, heart problems with an increase in heart rate, mouth sores, dryness, shortness of breath;
• Common: numbness in hands or feet, weakness and lack of energy, diarrhoea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, decrease in counts of white blood cells, fever, dry skin, back pain.

Interaction with other drugs: Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.

Storage:

• Store Bevatas 400mg Injection at 2˚C to 8˚C;
• Do not freeze or shake;
• Protect from light;
• Keep out of reach of children.

FAQ:

• Q1. Is Bevatas 400mg Injection used as standalone treatment in cancers?
• A1. Bevacizumab can be used as monotherapy or in combination with chemotherapy or immunotherapy medications.
• Q2. Is it safe for women to use Bevatas 400mg Injection?
• A2. Women with reproductive potential should discuss effective birth control methods with their doctor during and after treatment.
• Q3. Is it safe to undergo surgery during the treatment with Bevatas 400mg Injection?
• A3. Avoid surgery within 28 days before or after treatment due to the risk of bleeding complications and poor wound healing.
• Q4. Do the side effects of Bevatas 400mg Injection last for a chronic period?
• A4. Side effects occur until the drug concentration stays in the body, which can be up to 4 months after the final dose.
• Q5. How is Bevatas 400mg Injection administered?
• A5. Administered intravenously through infusion, with the amount of drug measured based on the patient’s body weight, height, and age. The first dose is administered for 90 minutes, and if well tolerated, the infusion time can be reduced to 30 minutes.
• Q6. Can I take Bevatas 400mg Injection if I am pregnant?
• A6. Inform your physician before starting treatment if you are pregnant or planning for pregnancy.

Fact box:

• Molecule name: Bevacizumab;
• Therapeutic class: Anticancer;
• Pharmacological class: VEGF Inhibitor.

Теги: medical-injection, bevatas-drug, anti-inflammatory-injection, pain-relief-injection, pharmaceutical-product